[MO42] Mini-Oral Session 42　Gastrointestinal Cancer 4（Colorectal Cancer 2）
【E】

[MO42-2] Dynamics of plasma VEGF-A, VEGF-D and PlGF after use of biologics in mCRC; Update report of the GI-SCREEN CRC Ukit study

^○Satoshi Yuki¹, Yu Sunakawa², Hiroya Taniguchi^3,4, Hideaki Bando⁴, Kentaro Yamazaki⁵, Tomohiro Nishina⁶, Takashi Ohta⁷, Tadamichi Denda⁸, Taito Esaki⁹, Hisato Kawakami¹⁰, Atsuo Takashima¹¹, Takeshi Kato¹², Koji Ando¹³, Toshikazu Moriwaki¹⁴, Taroh Satoh¹⁵, Yoshinaga Okugawa¹⁶, Yukiko Abe¹⁷, Shogo Nomura¹⁸, Chiharu Asano¹⁹, Takayuki Yoshino⁴ (1.Department of Gastroenterology and Hepatology, Hokkaido University Hospital, 2.Department of Clinical Oncology, St. Marianna University School of Medicine, 3.Department of Clinical Oncology, Aichi Cancer Center Hospital, 4.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 5.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 6.Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 7.Department of Clinical Oncology, Kansai Rosai Hospital, 8.Division of Gastroenterology, Chiba Cancer Center, 9.Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, 10.Department of Medical Oncology, Kindai University Faculty of Medicine, 11.Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 12.Department of Surgery, National Hospital Organization Osaka National Hospital, 13.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 14.Department of Gastroenterology, University of Tsukuba Hospital, 15.Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, 16.Division of Genomic Medicine, Mie University Hospital, 17.G&G Science Co., Ltd., 18.Clinical Research Support Office, National Cancer Center Hospital East, 19.Institute of Health Science Innovation for Medical Care (HELIOS), Hokkaido University Hospital)